Pilot Study on the Use of iENTER, iCONSENT and iPARTICIPATE E-tools
- Disease/Condition
- Cancer
- Study type
- Observational
- Primary sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Location
- Milano, Italy
- Phase
- N/A
- Start date
- Apr 05, 2023
- End date
- Jan 31, 2025
- Enrollment
- 30 participants
SUS questionnaire
Precision oncology is the future of fighting cancer. Cancer Core Europe (CCE) developed a
 precision medicine trial, i.e. the Basket of Basket (BoB) study, to provide personalised
 treatment to a large number of patients by incorporating a molecular profiling platform. The
 EU-funded CCE_DART project, developed within the CCE Consortium, is aimed at improving
 efficiency and transform platform trials into data-rich translational research programmes.
 Within the CCE_DART project working area D Patient involvement through information and
 partnership three interconnected web e-tools were developed aimed at promoting patient
 information, recruitment, and involvement as well as facilitating adherence to the CCE BoB
 trial: 1) iENTER: informative web site addressed to potential BoB trial participants, their
 caregivers, patients' advocates, and the public; 2) iCONSENT: web app for remote management
 of the informed consent process in the CCE BoB trial.3) iPARTICIPATE: web app allowing remote
 access to BoB trial patients trial visits calendar, medications list and posology, to upload
 documents and download reports, messaging between patients and clinical staff. The main
 objective of this study is to carry out field testing and assess usability of the e-tools
 iENTER, iCONSENT and iPARTICIPATE. The study is also addressed at collecting patients'
 suggestions for improvements of the e-tools.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06317961
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06317961 through Pure Global AI's free database. This phase not specified trial is sponsored by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano and is currently Recruiting. The study focuses on Cancer. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.